[Drug therapy of gastrointestinal motility disorders].
D000863:Antacids / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000188:drug therapy; D003680:Deglutition Disorders / Q000188:drug therapy; D003967:Diarrhea / Q000188:drug therapy; D004377:Dumping Syndrome / Q000188:drug therapy; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy*; D008787:Metoclopramide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014044:Tolbutamide / Q000627:therapeutic use
D000863:Antacids; D001285:Atropine; D014044:Tolbutamide; D011433:Propranolol; D008787:Metoclopramide; D002229:Carbenoxolone
Medikamentöse Therapei gastrointestinaler Motilitätsstörungen.